Cargando…

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants

BACKGROUND: Oral anticoagulant therapy (OAT) potently prevents strokes in patients with atrial fibrillation. Vitamin K antagonists (VKA) have been the standard of care for long-term OAT for decades, but non-VKA oral anticoagulants (NOAC) have recently been approved for this indication, and raised ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luger, Sebastian, Hohmann, Carina, Niemann, Daniela, Kraft, Peter, Gunreben, Ignaz, Neumann-Haefelin, Tobias, Kleinschnitz, Christoph, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664488/ https://www.ncbi.nlm.nih.gov/pubmed/26648702 http://dx.doi.org/10.2147/PPA.S88994

Ejemplares similares

Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
por: Bohmann, Ferdinand, et al.
Publicado: (2012)

Acute tetraparesis secondary to bilateral precentral gyral cerebral ischemia: a case report
por: Geis, Christian, et al.
Publicado: (2013)

Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke
por: Schuhmann, Michael K., et al.
Publicado: (2016)

Case-Control Study of Platelet Glycoprotein Receptor Ib and IIb/IIIa Expression in Patients with Acute and Chronic Cerebrovascular Disease
por: Kraft, Peter, et al.
Publicado: (2015)

Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study
por: Kraft, Peter, et al.
Publicado: (2015)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Diener, Hans-Christoph, et al.
Publicado: (2016)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional study
por: Batarfi, AbdulAziz, et al.
Publicado: (2020)

Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case–Control Study
por: Kraft, Peter, et al.
Publicado: (2014)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Viscoelastometry for detecting oral anticoagulants
por: Groene, Philipp, et al.
Publicado: (2021)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam
por: Tran, Minh-Hoang, et al.
Publicado: (2023)

Factors related to patient adherence to the use of new oral anticoagulants*
por: Lima, Paula Rocco Gomes, et al.
Publicado: (2021)

Direct oral anticoagulants: patient reported adherence and minor bleedings
por: Hayat, Amina, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
por: Pfeilschifter, Waltraud, et al.
Publicado: (2022)

Thrombolysis in a Stroke Patient on Dabigatran Anticoagulation: Case Report and Synopsis of Published Cases
por: Pfeilschifter, Waltraud, et al.
Publicado: (2013)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention
por: Vibo, Riina, et al.
Publicado: (2022)

Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes
por: Benavente, Lorena, et al.
Publicado: (2010)

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
por: Bellamy, L, et al.
Publicado: (2009)

New oral anticoagulants: discussion on monitoring and adherence should start now!
por: ten Cate, Hugo
Publicado: (2013)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

The role of oral anticoagulants in epistaxis
por: Buchberger, A. M. S., et al.
Publicado: (2018)

Patient Education on Oral Anticoagulation
por: Hawes, Emily M
Publicado: (2018)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
por: Brunkhorst, Robert, et al.
Publicado: (2013)

Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke
por: Luger, Sebastian, et al.
Publicado: (2018)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2rm72t0et6saq0ph7tu7fdrv1